Skip to main content

Table 1 Demographic data in 69 patients with juvenile idiopathic arthritis

From: A cross-sectional cohort study of the activity and turnover of neutrophil granulocytes in juvenile idiopathic arthritis

 

Patients on no medical treatment

n = 37

Patients on medical treatment

n = 32

Healthy children

n = 16

Female sex, n (%)

25 (68)

22 (69)

2 (12)

Age at disease onset, years, median (IQR)

6.8 (2.7–12.6)

4.0 (2.6–11.4)

 

Age at sampling, years, median (IQR)

9.9 (5.4–15.2)

12.8 (9.6–14.6)

5.3, (2.0–9.5)**

JADAS27 score

8.6 (5.8–12.8) (n = 34)

4.3 (1.3–8.1) (n = 29)*

 

JIA categories, course type

Number

Number

 

Oligoarticular persistent

18

12

 

Oligoarticular extended

3

3

 

Enthesitis-related arthritis

6

1

 

Polyarticular RF negative

6

8

 

Juvenile psoriatic arthritis

3

3

 

Undifferentiated arthritis

1

5

 

Medical treatment

 

Number

 

Methotrexate

 

14

 

Biological agent

 

7

 

Biological agent + methotrexate

 

11

 
  1. IQR interquartile range; JADAS27 juvenile arthritis disease activity score 27; RF rheumatoid factor
  2. *Mann-Whitney U, p = 0.002
  3. **Mann-Whitney U, p = 0.001